Market Share of Breast Cancer Liquid Biopsy Industry
The breast cancer liquid biopsy market is slightly fragmented and competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Janssen Diagnostics, Biocept Inc., Guardant Health Inc., Myriad Genetics, Adaptive Biotechnologies, Epic Sciences, Fluxion Biosciences Inc., Biodesix, and Illumina Inc.
Breast Cancer Liquid Biopsy Market Leaders
-
F. Hoffmann-La Roche Ltd
-
Bio-Rad Laboratories
-
Johnson & Johnson (Janssen Diagnostics)
-
Biocept Inc
-
Qiagen
*Disclaimer: Major Players sorted in no particular order